Cargando…
Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma
Thymic carcinoma is a highly malignant tumor and treatment options are limited. Lenvatinib, a novel multitargeted kinase inhibitor, has recently been approved for the treatment of unresectable thymic carcinoma. There are no reports of complete surgical resection after the administration of first‐lin...
Autores principales: | Shimura, Masatoshi, Miura, Kentaro, Koizumi, Tomonobu, Kanda, Shintaro, Mishima, Shuji, Hara, Daisuke, Matsuoka, Shunichiro, Eguchi, Takashi, Hamanaka, Kazutoshi, Uehara, Takeshi, Shimizu, Kimihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260480/ https://www.ncbi.nlm.nih.gov/pubmed/37132133 http://dx.doi.org/10.1111/1759-7714.14913 |
Ejemplares similares
-
Growing thymic granuloma adjacent to a thymic cyst mimicking malignancy: a case report
por: Takeda, Tetsu, et al.
Publicado: (2020) -
A Novel Strategy for the Diagnosis of Pulmonary High-Grade Neuroendocrine Tumor
por: Miura, Kentaro, et al.
Publicado: (2021) -
Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma
por: Miura, Kentaro, et al.
Publicado: (2021) -
Impact of counterclockwise rotation of the right middle lobe following right upper lobectomy
por: Koike, Sachie, et al.
Publicado: (2021) -
Significance of the evaluation of tracheal length using a three-dimensional imaging workstation
por: Matsuoka, Shunichiro, et al.
Publicado: (2022)